Meiho University Institutional Repository:Item 987654321/3111
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 2878/3799 (76%)
Visitors : 4077798      Online Users : 350
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.meiho.edu.tw/ir/handle/987654321/3111


    Title: Uric Acid Level as a Risk Marker for Chronic Kidney Disease: Data Analysis of Health Examinations
    Authors: Ya-Wen Chen;Sheng-Yuan Huang;Szu-Mei Hsiao;Chao-Hsien Lee;Chia-Hsin Lai;Tsan Yang
    Keywords: Chronic kidney disease;uric acid;glomerular filtration rate;health examination
    Date: 2015
    Issue Date: 2016-08-28T02:29:13Z (UTC)
    Abstract: Abstract: This study investigated uric acid levels as a risk marker for chronic kidney disease (CKD).This cross-sectional study focused on the 9,450 persons who attended the free health check at a hospital in Kaohsiung, Taiwan between July 2005 and July 2011. CKD was divided into non-CKD, CKD stages 1-2, and CKD stages 3-5. The 2002 National Kidney Foundation kidney disease outcomes quality initiative (K/DOQI) was used as the standard for diagnosis. Multiple logistic regression analysis was used to examine the influence of uric acid levels on CKD. The ratio of advanced stage diagnoses increased as uric acid levels increased; the results for CKD stages 3-5 were more significant. Multiple logistic regression analysis indicated that in models 1, 2, and 3, as uric acid levels increased, the risk for CKD stages 1-2 and stages 3-5 increased. This increased risk was more significant for CKD stages 3-5.The amount of kidney damage caused by CKD increases as uric acid levels increase. While controlling all other risk factors, uric acid can be used as an independent predictor for CKD.
    Relation: Sch. J. App. Med. Sci., 2015; 3(4C):1804-1809
    Appears in Collections:[Department of Health Business Administration] Papers

    Files in This Item:

    File Description SizeFormat
    1040807SJAMS-34C1804-1809.pdffulltext254KbAdobe PDF0View/Open


    All items in MUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback